Literature DB >> 19379796

Rodent models of glaucoma.

Thomas V Johnson1, Stanislav I Tomarev.   

Abstract

Glaucoma is a progressive, age-related optic neuropathy and a leading cause of irreversible blindness in the world. Animal models of glaucoma are essential to our continued efforts of elucidating the natural course of the disease and to developing therapeutic interventions to halt or reverse the progression of the condition. Over the past 10-15 years, rodents have become a popular model organism to study glaucoma, because of their high degree of availability, relatively low cost, short life-span, and amenability to experimental and genetic manipulation. In this review, we examine the numerous in vivo and in vitro rodent models of glaucoma, discuss the methods used to generate them, summarize some of the major findings obtained in these models, and identify individual strengths and weaknesses for the various systems. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19379796      PMCID: PMC2830899          DOI: 10.1016/j.brainresbull.2009.04.004

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  103 in total

1.  Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project.

Authors:  Anhchuong Le; Bickol N Mukesh; Catherine A McCarty; Hugh R Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.799

2.  Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies.

Authors:  J Fisher; H Levkovitch-Verbin; H Schori; E Yoles; O Butovsky; J F Kaye; A Ben-Nun; M Schwartz
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

3.  Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat.

Authors:  Michael Blair; Mary Ellen Pease; John Hammond; Danielle Valenta; Jennifer Kielczewski; Hana Levkovitch-Verbin; Harry Quigley
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-03       Impact factor: 4.799

4.  Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes.

Authors:  Kalliopi Stasi; Dalia Nagel; Xiaoyan Yang; Rong-Fang Wang; Lizhen Ren; Steven M Podos; Thom Mittag; John Danias
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

5.  Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy.

Authors:  Robert A Honkanen; Sankar Baruah; M Bridget Zimmerman; Cheryl L Khanna; Yaffa K Weaver; Joanna Narkiewicz; Rafiq Waziri; Karen M Gehrs; Thomas A Weingeist; H Culver Boldt; James C Folk; Stephen R Russell; Young H Kwon
Journal:  Arch Ophthalmol       Date:  2003-02

6.  Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma.

Authors:  Sonja Wamsley; B'Ann T Gabelt; David B Dahl; Gary L Case; Robert W Sherwood; Christian A May; M Rosario Hernandez; Paul L Kaufman
Journal:  Arch Ophthalmol       Date:  2005-01

Review 7.  Anterior eye development and ocular mesenchyme: new insights from mouse models and human diseases.

Authors:  Ales Cvekl; Ernst R Tamm
Journal:  Bioessays       Date:  2004-04       Impact factor: 4.345

8.  Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina.

Authors:  Won-Kyu Ju; Keun-Young Kim; Mila Angert; Karen X Duong-Polk; James D Lindsey; Mark H Ellisman; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-20       Impact factor: 4.799

9.  Photothrombosis-induced ischemic neuronal degeneration in the rat retina.

Authors:  J L Mosinger; J W Olney
Journal:  Exp Neurol       Date:  1989-07       Impact factor: 5.330

10.  Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus.

Authors:  Nadia De Marco; Mario Buono; Fulvia Troise; Graciana Diez-Roux
Journal:  J Biol Chem       Date:  2006-03-28       Impact factor: 5.157

View more
  60 in total

1.  Progressive degeneration of retinal and superior collicular functions in mice with sustained ocular hypertension.

Authors:  Hui Chen; Yan Zhao; Mingna Liu; Liang Feng; Zhen Puyang; Ji Yi; Peiji Liang; Hao F Zhang; Jianhua Cang; John B Troy; Xiaorong Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-26       Impact factor: 4.799

2.  Differential Misfolding Properties of Glaucoma-Associated Olfactomedin Domains from Humans and Mice.

Authors:  Athéna C Patterson-Orazem; Shannon E Hill; Yiming Wang; Iramofu M Dominic; Carol K Hall; Raquel L Lieberman
Journal:  Biochemistry       Date:  2019-03-12       Impact factor: 3.162

3.  Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma.

Authors:  Chaobin Lin; Fujin Wu; Tongmei Zheng; Xiuchun Wang; Yiwei Chen; Xiaomin Wu
Journal:  Eye (Lond)       Date:  2018-12-18       Impact factor: 3.775

4.  Reliability of Tonolab measurements in rats.

Authors:  Li-Fang Liu; Chu-Kai Huang; Ming-Zhi Zhang
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

5.  [Complement activation after induction of ocular hypertension in an animal model].

Authors:  S Becker; S Reinehr; H Burkhard Dick; S C Joachim
Journal:  Ophthalmologe       Date:  2015-01       Impact factor: 1.059

6.  Histological, morphometric, protein and gene expression analyses of rat retinas with ischaemia-reperfusion injury model treated with sildenafil citrate.

Authors:  Diogo S Zanoni; Germana A Da Silva; Raaya Ezra-Elia; Márcio Carvalho; Juliany G Quitzan; Ron Ofri; José L Laus; Renee Laufer-Amorim
Journal:  Int J Exp Pathol       Date:  2017-06       Impact factor: 1.925

7.  Magnetic resonance imaging indicates decreased choroidal and retinal blood flow in the DBA/2J mouse model of glaucoma.

Authors:  William J Lavery; Eric R Muir; Jeffrey W Kiel; Timothy Q Duong
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-01       Impact factor: 4.799

8.  Rat chronic glaucoma model induced by intracameral injection of microbeads suspended in sodium sulfate-sodium hyaluronate.

Authors:  Yoshiko Matsumoto; Akiyasu Kanamori; Makoto Nakamura; Akira Negi
Journal:  Jpn J Ophthalmol       Date:  2014-03-11       Impact factor: 2.447

Review 9.  Could adverse effects and complications of selective laser trabeculoplasty be decreased by low-power laser therapy?

Authors:  Alexandre de Carvalho Mendes Paiva; Adenilson de Souza da Fonseca
Journal:  Int Ophthalmol       Date:  2017-11-30       Impact factor: 2.031

10.  Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.

Authors:  Giselle Foureaux; José C Nogueira; Bárbara S Nogueira; Gustavo O Fulgêncio; Gustavo B Menezes; Simone O A Fernandes; Valbert N Cardoso; Renata S Fernandes; Gabriel P Oliveira; Juçara R Franca; André A G Faraco; Mohan K Raizada; Anderson J Ferreira
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-21       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.